Skip to main content

Bristol Myers Squibb signals beyond the news: 77+ signals from 8 sources

The latest Bristol Myers Squibb signal on this page is from Nov 17, 2026 (Patents): "Bristol-Myers Squibb was granted a patent for WEE1-degrading cancer compounds." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).

Public (BMY)Biotechnology Research10,000+ employeesbms.comLinkedIn

Get Bristol Myers Squibb's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bristol Myers Squibb this week? Use Autobound signals for bms.com.
Signals
77+
Sources
8
Last 90 days
46
Latest
Nov 17, 2026

Source: Autobound Signal API · 118 signals tracked for Bristol Myers Squibb · updated

Other signals · latest 10

Latest Bristol Myers Squibb signals by source

77+ signals for Bristol Myers Squibb across 8 sources.

  1. Patents · Patent grant

    Bristol-Myers Squibb was granted a patent for WEE1-degrading cancer compounds

    In November 2026 Bristol-Myers Squibb patented drug compounds designed for treating WEE1-related diseases, including cancer, in pharmaceutical and clinical settings.

    Patent title
    WEE1 degrading compounds and uses thereof
    Grant date
    Nov 17, 2026
    Inventors
    John Sapienza, Jennifer R. Riggs, Jacob T. Edwards, Daniel K. Cashion

    Google Patents

  2. Patents · Patent grant

    Bristol-Myers Squibb was granted a patent for crystalline drug forms.

    In November 2026 Bristol-Myers Squibb patented salt and crystal forms of a small-molecule compound for pharmaceutical development and medicine manufacturing.

    Patent title
    2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide salt and crystalline forms thereof
    Grant date
    Nov 17, 2026
    Inventors
    Prashant Mrityunjaya Sujata Kameshwar, Roopa Narasimhamurthy, Jennifer Nelson

    Google Patents

  3. Web traffic · Traffic snapshot

    bms.com received 1M monthly visits with traffic from 5 countries.

    Monthly visits
    1,070,767
    Month over month
    +0.1%
    3-month change
    +4.8%
    Global rank
    43,808
  4. Reddit · Leadership change

    Bristol Myers Squibb's head of R&D is departing the company amid an ongoing organizational restructure.

    Post: "BMS R&D head to depart amid restructure"

    Subreddit
    r/biotech
    Upvotes
    59
    Comments
    18
    Sentiment
    Negative

    r/biotech

  5. X (Twitter)

    Bristol-Myers Squibb merges Research and Drug Development into one organization led by Cristian Massacesi effective Jan. 1, 2027.

    We’re bringing Research & Drug Development together as one organization, led by Cristian Massacesi, effective Jan. 1, 2027. This new structure will strengthen our focus on advancing science and delivering for patients. https://t.co/yb9U9K9Z8y #OneBMS https://t.co/kGs8dPGOz7

    Account
    @bmsnews
    Views
    1,212
    Likes
    10
    Reposts
    0

    X (@bmsnews)

  6. Glassdoor · Layoff mentions

    Recent reviews identify significant redundancies and cold management response to staff cuts

    One employee reports frequent redundancies and describes higher management as cold, lacking empathy toward those impacted by staff reductions. This pattern suggests potential sensitivity around organizational restructuring and workforce planning.

    Overall rating
    3.7 of 5
    CEO approval
    67%
    Reviews read
    10
    Review window
    Nov 1, 2026 to Nov 10, 2026

    Glassdoor

  7. Website changes · Marketing content

    BMS added prominent homepage features for its Survivorship Today initiative and Global Patient Week program.

    Added links labeled “Featured initiatives” for “Survivorship Today” and “Global Patient Week.”

    Page
    /life-and-science.html

    bms.com

  8. Podcasts · Sponsorship

    Bristol Myers Squibb sponsors Tales from the Heart

    Ask your healthcare provider about the latest FDA-approved treatment, Mycorzo, Afacampin. A once-daily pill for adults with symptomatic OHCM to improve functional capacity and symptoms... Learn more at MyCorso.com or call 1-833-697-8796.

    Podcast
    Tales from the Heart
    Episode
    A New HCM Treatment Takes Shape

    Tales from the Heart

  9. Web traffic · Sustained growth

    bms.com shows sustained growth with 3 consecutive months of increases, up 21% overall to 1M.

    Minimal AI traffic at 0.8% (~9,061 visits). Top: chatgpt.com (82%), gemini.google.com (18%).

    Monthly visits
    1,099,815
    Month over month
    +7.6%
    3-month change
    +20.8%
    Global rank
    37,842
  10. LinkedIn

    Wishing everyone a happy and healthy New Year!

    Wishing everyone a happy and healthy New Year! Here’s to building on what we’ve learned and delivering meaningful progress for patients around the world in 2026. #OneBMS

    Likes
    922
    Comments
    14
    Tags
    Patient Experience, Medical Research, Corporate Strategy

    LinkedIn

Showing 10 of 77+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Bristol Myers Squibb with the Signal API

One POST /v1/companies/enrich call with bms.com returns Bristol Myers Squibb signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "bms.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Bristol Myers Squibb other signals

What signals does Autobound track for Bristol Myers Squibb besides news and filings?
This page lists 77+ signals for Bristol Myers Squibb from 8 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), X (Twitter) (13), Patents (11), Reddit (4), Podcasts (2) and Web traffic (2). Every row is dated, and most link to the post, review or record.
What are people saying about Bristol Myers Squibb online?
The newest posts on this page: Nov 12, 2026, Reddit (r/biotech): Bristol Myers Squibb's head of R&D is departing the company amid an ongoing organizational restructure. Nov 12, 2026, X (Twitter) (X (@bmsnews)): Bristol-Myers Squibb merges Research and Drug Development into one organization led by Cristian Massacesi effective Jan. 1, 2027. Nov 6, 2026, X (Twitter) (X (@bmsnews)): Bristol-Myers Squibb shares positive 56-week Phase 3 pediatric oHCM trial results at HCMSCHICAGO.
What do employees say about working at Bristol Myers Squibb?
The newest Glassdoor theme on this page, dated Nov 10, 2026: Recent reviews identify significant redundancies and cold management response to staff cuts. The overall rating in that row is 3.7 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Bristol Myers Squibb been granted patents recently?
Yes. The newest grant on this page: Nov 17, 2026, Patents (Google Patents): Bristol-Myers Squibb was granted a patent for WEE1-degrading cancer compounds.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →